from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1525/wbbL2

LFCtreatmentdescriptionclass of inhibitor

-0.831

Amikacinug/mL Amikacintranslation

-1.487

Cap5-10ug/mL Capreomycintranslation

-1.846

Rox10-50 ug/mL Roxithromycintranslation

-0.273

SM2-5 ug/mL Streptomycintranslation

-1.129

Tet5-10 ug/mL Tetracyclinetranslation

1.714

Rif0.2-5ug/mL Rifampicintranscription

0.805

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.041

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.052

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.540

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.539

Clofazimine10-13 ug/mL Clofaziminerespiration

0.065

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.513

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.337

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.836

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.136

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.658

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.564

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.196

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.203

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.290

KCN5-20 ug/mL Potassium cyaniderespiration

-0.227

NaN30.2-2 mM Sodium aziderespiration

-0.637

Nigericin50 uM Nigericinrespiration

0.075

TRC10-150 ug/mL Triclosanrespiration

0.258

TRZ10-25 ug/mL Thioridazinerespiration

-0.108

Valinomycin0.5-10 uM Valinomycinrespiration

-0.426

ZnSO42 mM ZnSO4respiration

-0.749

menadione6-10 ug/mL Menadionerespiration

-0.572

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.028

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.174

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.535

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.716

NRP_1Non-replicating persistence stage 1dosRassociated

0.417

Amp0.2mg/mL AmpicillincellWall

0.107

Cephalexin20-100 ug/mL CephalexincellWall

-0.768

Cerulenin0.32-5 ug/mL CerulenincellWall

0.905

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.386

EMB10-20 ug/mL EthambutolcellWall

-0.457

Eta12-40 ug/mL EthionamidecellWall

-0.427

INH0.2-0.4 ug/mL IsoniazidcellWall

0.192

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.630

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.018

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.459

BZA0.12 mg/mL BenzamidearomaticAmides

0.592

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.239

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.451

H2O24 mM hydrogen peroxideDNAdamaging

-0.102

Levo10 ug/mL LevofloxacinDNAdamaging

0.528

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.147

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.095

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.882

UVUV-irradiationDNAdamaging

0.307

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.629

Antimycin12.5-50 ug/mL Antimycin A?

-0.029

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.524

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.605

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.334

PA8240.2-2 ug/mL PA-824?

-0.398

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.052

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.180

Verapamil50 uM Verapamil?

0.009

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.824

methoxatin10-20 ug/mL Methoxatin?